Evidence map›Paper›PMID 34541531›Full record

ArticleBrain communications2021

Advanced brain ageing in Parkinson's disease is related to disease duration and individual impairment.

Claudia R Eickhoff, Felix Hoffstaedter, Julian Caspers, Kathrin Reetz, Christian Mathys, Imis Dogan, Katrin Amunts, Alfons Schnitzler, Simon B Eickhoff

Open access · goldAbstract read
In one paragraph

Article in Brain communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Neonatal brain-age models in full- and preterm infants.Developmental cognitive neuroscience · 2026
    Article
  3. Article
  4. Review
  5. [Research progress on intelligent brain age prediction methods in diagnosis of Parkinson's disease].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026
    Review
  6. Article
  7. Review
  8. Midbrain length by the one-line method predicts motor outcome after deep brain stimulation in Parkinson's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  9. Neonatal brain-age models in full- and preterm infants.bioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. When Age Is More Than a Number: Acceleration of Brain Aging in Neurodegenerative Diseases.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  15. Advanced brain aging, selective vulnerability in gray matter, and cognition in Parkinson's disease.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Claudia R EickhoffInstitute of Neuroscience and Medicine (INM-1, INM-7, INM-11), Jülich, Germany.
Felix HoffstaedterInstitute of Neuroscience and Medicine (INM-1, INM-7, INM-11), Jülich, Germany.
Julian CaspersInstitute of Diagnostic and Interventional Radiology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Kathrin ReetzInstitute of Neuroscience and Medicine (INM-1, INM-7, INM-11), Jülich, Germany.ORCID https://orcid.org/0000-0002-9730-9228
Christian MathysEvangelisches Krankenhaus Oldenburg, Oldenburg, Germany.
Imis DoganInstitute of Neuroscience and Medicine (INM-1, INM-7, INM-11), Jülich, Germany.
Katrin AmuntsInstitute of Neuroscience and Medicine (INM-1, INM-7, INM-11), Jülich, Germany.
Alfons SchnitzlerInstitute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Simon B EickhoffInstitute of Neuroscience and Medicine (INM-1, INM-7, INM-11), Jülich, Germany.ORCID https://orcid.org/0000-0001-6363-2759
Heinrich Heine University Düsseldorf · DERWTH Aachen University · DEEvangelisches Krankenhaus Oldenburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Machine learning can reliably predict individual age from MRI data, revealing that patients with neurodegenerative disorders show an elevated biological age. A surprising gap in the literature, however, pertains to Parkinson's disease. Here, we evaluate brain age in two cohorts of Parkinson's patients and investigated the relationship between individual brain age and clinical characteristics. We assessed 372 patients with idiopathic Parkinson's disease, newly diagnosed cases from the Parkinson's Progression Marker Initiative database and a more chronic local sample, as well as age- and sex-matched healthy controls. Following morphometric preprocessing and atlas-based compression, individual brain age was predicted using a multivariate machine learning model trained on an independent, multi-site reference sample. Across cohorts, healthy controls were well predicted with a mean error of 4.4 years. In turn, Parkinson's patients showed a significant (controlling for age, gender and site) increase in brain age of ∼3 years. While this effect was already present in the newly diagnosed sample, advanced biological age was significantly related to disease duration as well as worse cognitive and motor impairment. While biological age is increased in patients with Parkinson's disease, the effect is at the lower end of what is found for other neurological and psychiatric disorders. We argue that this may reflect a heterochronicity between forebrain atrophy and small but behaviourally salient midbrain pathology. Finally, we point to the need to disentangle physiological ageing trajectories, lifestyle effects and core pathological changes.

Indexed as

ageatrophymachine learningParkinson’sprediction

Identifiers

PMID34541531
PMCPMC8445399
OpenAlexW3194973925

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.